Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)
CNY 14.08
(-0.77%)
CNY 14.08
(-0.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 219.34 Million | 13.04 Million | 82.85 Million | 113.63 Million | 65.91 Million | 31.79 Million |
| Net Income | 32.69 Million | 98.4 Million | 91.78 Million | 119.18 Million | 169.74 Million | 137.37 Million |
| Depreciation & Amortization | 82.1 Million | 74.69 Million | 69.83 Million | 46.89 Million | 23.65 Million | 21.57 Million |
| Deferred income taxes | 3.34 Million | -1.67 Million | 1.45 Million | -6.79 Million | -6.44 Million | -1.14 Million |
| Stock-based compensation | - | - | -1.4 Million | 4.02 Million | - | - |
| Change in working capital | 95.82 Million | -182.94 Million | -99.03 Million | -64.32 Million | -133.71 Million | -129.35 Million |
| Other non-cash items | 8.7 Million | 22.89 Million | 20.22 Million | 14.65 Million | 6.22 Million | 2.2 Million |
| Investing Cash Flow | -157.34 Million | -5.29 Million | -108.54 Million | 87.32 Million | -269.67 Million | 143.54 Million |
| Investments in PPE | -92.81 Million | -60.61 Million | -56.63 Million | -46.68 Million | -64.66 Million | -36.29 Million |
| Acquisitions | - | 0.06 | 1.00 | 46.69 Million | 64.67 Million | 36.3 Million |
| Investment purchases | -65.38 Million | -77.96 Million | -113 Million | -265.5 Million | -465 Million | -274 Million |
| Sales/Maturities of investments | 862.76 Thousand | 133.28 Million | 61.09 Million | 399.51 Million | 259.98 Million | 453.83 Million |
| Other Investing Activities | 0.10 | - | 0.42 | -46.68 Million | -64.66 Million | -36.29 Million |
| Financing Cash Flow | -30.22 Million | -32.34 Million | -25.65 Million | -6.08 Million | 247.34 Million | 674.36 Thousand |
| Debt repayment | -70 Million | -2.04 Million | -12 Million | -12 Million | -48.7 Million | -17 Million |
| Dividends payments | -29.23 Million | -20 Million | -11.24 Million | -17.67 Million | -14 Million | -29.61 Million |
| Common Stock Repurchased | - | -7.11 Million | -226.86 Thousand | -414.47 Thousand | - | - |
| Common Stock Issuance | - | 9.15 Million | 226.86 Thousand | - | - | - |
| Other Financing Activities | -63.51 Thousand | -9.3 Million | -258.06 Thousand | 13.7 Million | 310.88 Million | 47.28 Million |
| Accounts receivables | 84.86 Million | -85.86 Million | -16.38 Million | 68.32 Million | -26.73 Million | -17.82 Million |
| Accounts payables | 45.63 Million | -106.82 Million | -75.39 Million | -93.5 Million | -70.65 Million | -105 Million |
| Inventory | -38.01 Million | 11.42 Million | -8.7 Million | -32.34 Million | -29.87 Million | -5.37 Million |
| Other working capital | 3.34 Million | -1.67 Million | 1.45 Million | -6.79 Million | -6.44 Million | -123.97 Million |
| Cash at beginning of period | 405.72 Million | 429.96 Million | 481.4 Million | 286.79 Million | 243.31 Million | 67.3 Million |
| Cash at end of period | 437.56 Million | 405.72 Million | 429.96 Million | 481.4 Million | 286.79 Million | 243.31 Million |
| Capital Expenditure | -92.81 Million | -60.61 Million | -56.63 Million | -46.68 Million | -64.66 Million | -36.29 Million |
| Effect of forex changes on cash | 70.89 Thousand | 352.02 Thousand | -88.12 Thousand | -270.24 Thousand | -105.26 Thousand | 1.00 |
| Net cash flow / Change in cash | 31.83 Million | -24.24 Million | -51.43 Million | 194.6 Million | 43.47 Million | 176.01 Million |
| Free Cash Flow | 126.52 Million | -47.57 Million | 26.21 Million | 66.94 Million | 1.25 Million | -4.5 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 27.36 Million | 6.86 Million | 40.35 Million | 32.69 Million | -12.07 Million | 3.41 Million |
| Depreciation & Amortization | - | 21.27 Million | 21.27 Million | 82.1 Million | 21.25 Million | -39.33 Million |
| Deferred income taxes | -2.26 Million | - | - | 3.34 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 95.82 Million | 46.84 Million | -27.32 Million |
| Other non-cash items | 18.5 Million | 70.34 Million | -31.49 Million | 8.7 Million | 29.88 Million | 90.02 Million |
| Investing Cash Flow | -53.69 Million | -180.06 Million | -3.57 Million | -157.34 Million | -54.9 Million | -11.37 Million |
| Investments in PPE | -4.76 Million | -4.06 Million | -3.57 Million | -92.81 Million | -4.83 Million | -11.37 Million |
| Acquisitions | - | 3500.00 | - | - | - | - |
| Investment purchases | -240 Million | -199.58 Million | - | -65.38 Million | -50.38 Million | - |
| Sales/Maturities of investments | 191.07 Million | 23.58 Million | - | 862.76 Thousand | 322.39 Thousand | - |
| Other Investing Activities | - | -175.96 Million | - | 0.10 | 0.85 | - |
| Financing Cash Flow | -14.65 Million | -20.87 Million | -100.2 Thousand | -30.22 Million | -54.5 Thousand | -70.38 Million |
| Debt repayment | - | - | - | -70 Million | - | -70 Million |
| Dividends payments | -14.61 Million | - | - | -29.23 Million | - | -349.99 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -38.16 Thousand | -20.77 Million | -100.2 Thousand | -63.51 Thousand | -54.5 Thousand | -38.16 Thousand |
| Accounts receivables | - | - | - | 84.86 Million | 84.86 Million | -65.58 Million |
| Accounts payables | - | - | - | 45.63 Million | - | - |
| Inventory | - | - | - | -38.01 Million | -38.01 Million | 38.26 Million |
| Other working capital | - | - | - | 3.34 Million | - | - |
| Cash at beginning of period | 297.75 Million | 442.74 Million | 437.56 Million | 405.72 Million | 453.53 Million | 508.52 Million |
| Cash at end of period | 271.45 Million | 297.75 Million | 442.74 Million | 437.56 Million | 437.56 Million | 453.53 Million |
| Capital Expenditure | -4.76 Million | -4.06 Million | -3.57 Million | -92.81 Million | -4.83 Million | -11.37 Million |
| Effect of forex changes on cash | -72.14 Thousand | 19.15 Thousand | 7308.33 | 70.89 Thousand | -73.65 Thousand | -11.18 Thousand |
| Net cash flow / Change in cash | -26.29 Million | -144.99 Million | 5.18 Million | 31.83 Million | -15.96 Million | -54.99 Million |
| Free Cash Flow | 38.84 Million | 51.86 Million | 5.27 Million | 126.52 Million | 34.22 Million | 15.4 Million |
MUX
IXC
1289
RCC
KHNGF
IMCC